Terms: = Prostate cancer AND CBFB, PEBP2B, 865, ENSG00000067955, Q13951 AND Diagnosis
11 results:
1. Development of a prognostic model for long-term survival of young patients with bladder cancer: a retrospective analysis of the SEER Database.
Guo L; Liu L; Liu Y; Yang T; Wang G; Liu J; Li S; Cai J
BMJ Open; 2024 Mar; 14(3):e080092. PubMed ID: 38458812
[TBL] [Abstract] [Full Text] [Related]
2. Costs to Medicare of Nonrecommended Bone-Modifying Agent Use for Castration-Sensitive prostate cancer.
Mitchell AP; Nemirovsky D; Mishra Meza A; Chakraborty N; Persaud S; Farooki A; Morris MJ
JCO Oncol Pract; 2024 Mar; 20(3):393-400. PubMed ID: 38190588
[TBL] [Abstract] [Full Text] [Related]
3. Correlations between serum levels of microRNA-148a-3p and microRNA-485-5p and the progression and recurrence of prostate cancer.
He W; Zhang F; Jiang F; Liu H; Wang G
BMC Urol; 2022 Nov; 22(1):195. PubMed ID: 36434610
[TBL] [Abstract] [Full Text] [Related]
4. Trends for Stage and Grade Group of prostate cancer in the US (2010-2016).
Schmanke K; Okut H; Ablah E
Urology; 2021 Mar; 149():110-116. PubMed ID: 33227304
[TBL] [Abstract] [Full Text] [Related]
5. Temporal trends in loss of life expectancy after a cancer diagnosis among the Australian population.
Kou K; Dasgupta P; Cramb SM; Yu XQ; Andersson TM; Baade PD
Cancer Epidemiol; 2020 Apr; 65():101686. PubMed ID: 32062407
[TBL] [Abstract] [Full Text] [Related]
6. Reducing Unnecessary prostate Multiparametric Magnetic Resonance Imaging by Using Clinical Parameters to Predict Negative and Indeterminate Findings.
Deniffel D; Zhang Y; Salinas E; Satkunasivam R; Khalvati F; Haider MA
J Urol; 2020 Feb; 203(2):292-298. PubMed ID: 31479397
[TBL] [Abstract] [Full Text] [Related]
7. prostate cancer Differentiation and Aggressiveness: Assessment With a Radiomic-Based Model vs. PI-RADS v2.
Chen T; Li M; Gu Y; Zhang Y; Yang S; Wei C; Wu J; Li X; Zhao W; Shen J
J Magn Reson Imaging; 2019 Mar; 49(3):875-884. PubMed ID: 30230108
[TBL] [Abstract] [Full Text] [Related]
8. prostate Specific Antigen, Mean Platelet Volume, and Platelet Distribution Width in Combination to Discriminate prostate cancer from Benign prostate Hyperplasia.
Fu S; Zhang X; Niu Y; Wang RT
Asian Pac J Cancer Prev; 2018 Mar; 19(3):699-702. PubMed ID: 29580043
[TBL] [Abstract] [Full Text] [Related]
9. Risk Stratification Among Men With prostate Imaging Reporting and Data System version 2 Category 3 Transition Zone Lesions: Is Biopsy Always Necessary?
Felker ER; Raman SS; Margolis DJ; Lu DSK; Shaheen N; Natarajan S; Sharma D; Huang J; Dorey F; Marks LS
AJR Am J Roentgenol; 2017 Dec; 209(6):1272-1277. PubMed ID: 28858541
[TBL] [Abstract] [Full Text] [Related]
10. Intraductal Carcinoma of the prostate on Diagnostic Needle Biopsy Predicts prostate cancer Mortality: A Population-Based Study.
Saeter T; Vlatkovic L; Waaler G; Servoll E; Nesland JM; Axcrona K; Axcrona U
Prostate; 2017 Jun; 77(8):859-865. PubMed ID: 28240424
[TBL] [Abstract] [Full Text] [Related]
11. Trends in PET Scan Usage for Imaging of Patients Diagnosed With Nonmetastatic Urologic cancer.
Adejoro O; Alishahi A; Soubra A; Konety B
Clin Genitourin Cancer; 2016 Feb; 14(1):38-47.e1. PubMed ID: 26525859
[TBL] [Abstract] [Full Text] [Related]
